As was seen with the cell lines, CoCl2 treatment upregulates WT1 expression (Fig. 8C) and causes hypomethylation of the Intron 1 CpG island (Fig. 8D) in the WT1-negative AML samples. The gene discussed is WT1; the disease is acute myeloid leukemia.